00:06 , May 16, 2019 |  BC Extra  |  Clinical News

May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven

Abstracts were released late Wednesday ahead of the American Society of Clinical Oncology meeting starting May 31 in Chicago. See below for BioCentury's first round of Quick Takes on selected abstracts. Iovance gains on 44%...
21:15 , Sep 28, 2018 |  BioCentury  |  Finance

Activating Akrevia

Akrevia Therapeutics LLC parlayed preclinical proof-of-concept data from its tumor-activated therapies into a $30 million series A round co-led by Atlas Venture and F-Prime Capital Partners. Akrevia, which emerged from stealth on Sept. 27, uses...
17:56 , Sep 28, 2018 |  BC Week In Review  |  Financial News

F-Prime, Atlas lead Akrevia's $30M series A

Immunotherapy company Akrevia Therapeutics LLC (Cambridge, Mass.) launched on Sept. 27 with a $30 million series A round co-led by F-Prime Capital Partners and Atlas Venture. Akrevia’s Aklusion platform enables biological molecules such as antibodies,...
15:37 , Sep 27, 2018 |  BC Extra  |  Financial News

F-Prime, Atlas lead Akrevia's $30M series A

Immunotherapy company Akrevia Therapeutics LLC (Cambridge, Mass.) launched with a $30 million series A round co-led by F-Prime Capital Partners and Atlas Venture. Akrevia’s Aklusion platform enables biological molecules such as antibodies, cytokines and chemokines...
17:27 , Sep 14, 2018 |  BC Week In Review  |  Company News

Takeda to move U.S. headquarters to Boston area

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will move its U.S. headquarters from Deerfield, Ill., to a to-be-determined site in the greater Boston area after its planned acquisition of Shire plc (LSE:SHP; NASDAQ:SHPG) closes next half. Takeda...
05:06 , Sep 12, 2018 |  BC Extra  |  Company News

Takeda to move U.S. headquarters to Boston

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will move its U.S. headquarters from Deerfield, Ill., to a to-be-determined site in the greater Boston area after its planned acquisition of Shire plc (LSE:SHP; NASDAQ:SHPG) closes next half. Takeda...
20:07 , Jul 25, 2018 |  BC Extra  |  Company News

Management Tracks: Albireo, ObsEva

Pediatric liver disease company Albireo Pharma Inc. (NASDAQ:ALBO) said CMO Paresh Soni will step down. He is succeeded by Patrick Horn, who was SVP of medical and clinical development at Orphan Technologies Ltd. (Rapperswil, Switzerland)....
19:00 , Jun 1, 2018 |  BC Week In Review  |  Company News

Ironwood shareholders vote to keep board intact

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) said its shareholders re-elected all three of its preferred board director nominees during its annual shareholder meeting. Alex Denner, who holds about a 2.2% stake in Ironwood and is chief investment...
21:51 , May 31, 2018 |  BC Extra  |  Company News

Ironwood shareholders opt to keep board intact

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) said its shareholders re-elected all three of its preferred board director nominees during its annual shareholder meeting. Alex Denner, who holds about a 2.2% stake in Ironwood and is chief investment...
22:48 , May 25, 2018 |  BC Extra  |  Company News

Management tracks: ISA, ImCheck, ArQule

Immunotherapy company ISA Pharmaceuticals B.V. (Leiden, the Netherlands) promoted CBO Gerben Moolhuizen to CEO, effective June 1. He succeeds CEO Ronald Loggers. Also in May, ISA hired Leon Hooftman as CMO. Hooftman was CMO at...